The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose
- PMID: 34724399
- DOI: 10.7326/ACPJ202111160-124
The Novavax vaccine had 90% efficacy against COVID-19 ≥7 d after the second dose
Abstract
Heath PT, Galiza EP, Baxter DN, et al. Safety and efficacy of NVX-CoV2373 Covid-19 vaccine. N Engl J Med. 2021;385:1172-83. 34192426.
Comment on
-
Safety and Efficacy of NVX-CoV2373 Covid-19 Vaccine.N Engl J Med. 2021 Sep 23;385(13):1172-1183. doi: 10.1056/NEJMoa2107659. Epub 2021 Jun 30. N Engl J Med. 2021. PMID: 34192426 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical